It's fall, y'all, and you know what that means—temperatures and leaves drop, football season is in full swing, pumpkin spice ...

A phase 2 study shows that azelastine nasal spray lowered coronavirus infection rates to 2.2% compared to 6.7%, researchers ...

The 2-1 decision of the 9th Circuit in the case of an employee’s COVID-19 testing exemption lawsuit splits from other ...

OKAYAMA--More than half of patients who visited Okayama University Hospital’s COVID-19 aftercare (CAC) outpatient clinic ...

Symptomatic or viral rebound is estimated to occur in 0.8% to 32% of Paxlovid recipients and 1.1% to 31% of those who receive ...

A common nasal spray may lower the risk of getting Covid-19, a new study shows. Dr. Leana Wen discusses what this all means as coronavirus cases rise.

The COVID-19 virus is surging locally and nationwide. Unfortunately confusion is also mounting regarding its treatment and ...

The days of free at-home COVID-19 tests may be over, but the virus certainly hasn’t gone away. With symptoms that overlap ...

Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a ...

The screening itself is a blood test, the prostate-specific antigen test. And it will be conducted by licensed medical staff.

The symptoms of XFG closely resemble those of other COVID variants, Weber said, and may include: Yes. Studies have shown rapid antigen tests can detect a variety of COVID variants, including XFG, ...